Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Assets: 2023-2024

Historic Assets for Upstream Bio (UPB) over the last 2 years, with Dec 2024 value amounting to $481.7 million.

  • Upstream Bio's Assets rose 68.11% to $391.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $391.2 million, marking a year-over-year increase of 68.11%. This contributed to the annual value of $481.7 million for FY2024, which is 311.03% up from last year.
  • Upstream Bio's Assets amounted to $481.7 million in FY2024, which was up 311.03% from $117.2 million recorded in FY2023.
  • In the past 5 years, Upstream Bio's Assets registered a high of $481.7 million during FY2024, and its lowest value of $117.2 million during FY2023.
  • Moreover, its 2-year median value for Assets was $299.5 million (2023), whereas its average is $299.5 million.
  • Data for Upstream Bio's Assets shows a peak YoY skyrocketed of 311.03% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows Upstream Bio's Assets stood at $117.2 million in 2023, then spiked by 311.03% to $481.7 million in 2024.